痣样基底细胞癌综合征1例报道

›› 2019, Vol. 39 ›› Issue (12): 1127-1130.

痣样基底细胞癌综合征1例报道

任俊¹,郭丽娟²,杨森³

1. 遂宁市中心医院
2. 遵义医科大学口腔医学院口腔颌面外科
3. 四川省遂宁市中心医院口腔科

收稿日期:2019-03-13 修回日期:2019-05-13 出版日期:2019-12-28 发布日期:2019-12-31
通讯作者: 杨森 E-mail:42831594@qq.com
基金资助:
四川省科技重点研发项目

A case report of nevoid basal cell carcinoma syndrome

Received:2019-03-13 Revised:2019-05-13 Online:2019-12-28 Published:2019-12-31
Contact: - -- E-mail:42831594@qq.com

摘要/Abstract

摘要： 痣样基底细胞癌综合征(nevoid basal cell carcinoma syndrome,NBCCS)是一种少见的常染色体显性遗传病，临床表现多达一百多种，主要临床表现为皮肤基底细胞癌，颌骨牙源角化囊性瘤（odontogenic keratocystic tumor, OKC），手掌及脚底的过度角化、点状凹陷，颅骨异常，小脑镰钙化，眶距增宽，面部畸形，巨头巨脑畸形，唇腭裂等。本文报告1例痣样基底细胞癌综合征，并结合相关文献对该病的发病机制、发病率、临床表现、诊断、治疗方法等进行讨论。

关键词: 痣样基底细胞癌综合征, 牙源性角化囊性瘤, 诊断, 治疗

Abstract: Nevoid basal cell carcinoma syndrome (NBCCS) is a rare autosomal dominant hereditary disease with more than 100 clinical manifestations, whose main clinical manifestations are skin basal cell carcinoma, odontogenic keratocystic tumor (OKC), excessive keratosis, pitting of the palms and soles of the feet, skull abnormality and falciparum calcification, orbital spacing widening, facial deformity, giant brain deformity, cleft lip and palate, etc. A case of nevoid basal cell carcinoma syndrome is reported in this paper. The pathogenesis, incidence, clinical manifestation, diagnosis and treatment of the disease are discussed in combination with relevant literature.

Key words: Naevoid basal cell carcinoma syndrome, odontogenic keratocystic tumor, diagnosis, treatment

中图分类号:

　R739.82

任俊郭丽娟杨森. 痣样基底细胞癌综合征1例报道[J]. , 2019, 39(12): 1127-1130.

参考文献 23

[1]	刘冰.牙源性角化囊肿外科治疗策略[C]//第十四次中国口腔颌面外科学术会议论文集. 重庆, 2018: 49.
[2]	Gorlin RJ, Goltz RW.Multiple nevoid basal-cell epithelioma,jaw cysts and bifid rib[J].N Engl J Med, 1960, 262(18):908-912
[3]	Dos Santos JL, Delgado RZR, de Oliveira GR, et al.Odontogenic keratocysts as first manifestation of nevoid basal cell carcinoma syndrome: surgical management and immunohistochemical analysis[J].J Craniofac Surg, 2018, 29(6):1588-1590
[4]	Seo DU, Kim SG, Oh JS, et al.Treatment of nevoid basal cell carcinoma syndrome: a case report[J].J Korean Assoc Oral Maxillofac Surg, 2016, 42(5):284-287
[5]	Ali IK, Karjodkar FR, Sansare K, et al.Nevoid basal cell carcinoma syndrome - clinical and radiological findings of three cases[J].Cureus, 2016, 8(8):e727-
[6]	Lo Muzio L.Nevoid basal cell carcinoma syndrome (Gorlin syndrome)[J]. Orphanet J Rare Dis, 2008, 3: 32.
[7]	Yasar B, Byers HJ, Smith MJ, et al.Common variants modify the age of onset for basal cell carcinomas in Gorlin syndrome[J].Eur J Hum Genet, 2015, 23(5):708-710
[8]	Kato C, Fujii K, Arai Y, et al.Nevoid basal cell carcinoma syndrome caused by splicing mutations in the PTCH1 gene[J].Fam Cancer, 2017, 16(1):131-138
[9]	Shiohama T, Fujii K, Miyashita T, et al.Brain morphology in children with nevoid basal cell carcinoma syndrome[J].Am J Med Genet A, 2017, 173(4):946-952
[10]	Durmaz CD, Evans G, Smith MJ, et al.A novel PTCH1 frameshift mutation leading to nevoid basal cell carcinoma syndrome[J].Cytogenet Genome Res, 2018, 154(2):57-61
[11]	Sim YC, Kim GH, Choi SW, et al.Novel PTCH1 gene mutation in nevoid basal cell carcinoma syndrome[J].J Craniofac Surg, 2018, 29(3):e252-e255
[12]	Smith MJ, Beetz C, Williams SG, et al.Germline mutations in SUFU cause Gorlin syndrome-associated childhood medulloblastoma and redefine the risk associated with PTCH1 mutations[J].J Clin Oncol, 2014, 32(36):4155-4161
[13]	Athar M, Li CZ, Kim AL, et al.Sonic hedgehog signaling in Basal cell nevus syndrome[J].Cancer Res, 2014, 74(18):4967-4975
[14]	Silapunt S, Chen L, Migden MR.Hedgehog pathway inhibition in advanced basal cell carcinoma: latest evidence and clinical usefulness[J].Ther Adv Med Oncol, 2016, 8(5):375-382
[15]	Pino LC, Balassiano LK, Sessim M, et al.Basal cell nevus syndrome: clinical and molecular review and case report[J].Int J Dermatol, 2016, 55(4):367-375
[16]	高第, 黄二顺, 孙婷婷, 等.痣样基底细胞癌综合征一家系基因突变分析[J].中华皮肤科杂志, 2014, 47(12):860-863
[17]	Marsh A, Wicking C, Wainwright B, et al.DHPLC analysis of patients with Nevoid Basal Cell Carcinoma Syndrome reveals novel PTCH missense mutations in the sterol-sensing domain[J].Hum Mutat, 2005, 26(3):283-
[18]	Bresler SC, Padwa BL, Granter SR.Nevoid basal cell carcinoma syndrome (gorlin syndrome)[J].Head Neck Pathol, 2016, 10(2):119-124
[19]	Evans DG, Ladusans EJ, Rimmer S, et al.Complications of the naevoid basal cell carcinoma syndrome: results of a population based study[J].J Med Genet, 1993, 30(6):460-464
[20]	Kimonis VE, Goldstein AM, Pastakia B, et al.Clinical manifestations in 105 persons with nevoid basal cell carcinoma syndrome[J].Am J Med Genet, 1997, 69(3):299-308
[21]	Qu JF, Yu FY, Hong YY, et al.Underestimated PTCH1 mutation rate in sporadic keratocystic odontogenic tumors[J].Oral Oncol, 2015, 51(1):40-45
[22]	Ponti G, Manfredini M, Pastorino L, et al.PTCH1 germline mutations and the basaloid follicular hamartoma values in the tumor spectrum of basal cell carcinoma syndrome (NBCCS)[J].Anticancer Res, 2018, 38(1):471-476
[23]	Pereira T, Tamgadge A, Sapdhare S, et al.Multiple keratocystic odontogenic tumors in nevoid basal cell carcinoma syndrome[J].Ann Maxillofac Surg, 2015, 5(2):277-280